Today, the hybrid (virtual and @WIPO)Standing Committee on Copyright and Related Rights meeting went more smoothly than yesterday. The tech was checked and tested before the meeting and except for a few statements (some visual or audio failures) we heard… Continue Reading →
On Friday, 17 July 2020, South Africa submitted a paper to the World Trade Organization (WTO) TRIPS Council entitled, Intellectual Property and the Public Interest: Beyond Access to Medicines and Medical Technologies Towards a More Holistic Approach To TRIPS Flexibilities.… Continue Reading →
This annotated bibliography of (mostly scholarly and technical) articles and books on innovation prizes is a work on progress. In the past few years, there has been an explosion of research on innovation inducement prizes, much of which has yet… Continue Reading →
On March 31st, 2020, the Office of the United States Trade Representative (USTR) published its 2020 National Trade Estimates Report on Foreign Trade Barriers (NTE). As USTR notes, in “accordance with section 181 of the Trade Act of 1974, as… Continue Reading →
On Friday, 14 February 2020, Knowledge Ecology International (KEI) submitted the following comments on the Draft General Comment on Science and economic, social and cultural rights prepared by the the Committee on Economic, Social and Cultural rights (CESCR). The draft… Continue Reading →
KEI Comments on Intellectual Property Protection for Artificial Intelligence Innovation, for USPTO Request for Comments Re: 84 FR 66176, Docket No. PTO-C-2019-0038 10 January 2020 1. Should a work produced by an AI algorithm or process, without the involvement of… Continue Reading →
On April 30, 2019, KEI issued a memorandum to Congress concerning recent proposed measures to cap drug price increases and to increase the transparency of pharmaceutical research and development costs. Congress is currently considering several bills that touch on these… Continue Reading →
For a general timeline of the Bayh-Dole Act, see this page. 1980. December 12. The Bayh-Dole Act was enacted into law as part of Public Law 96-517, including Section 203 that provide march-in rights. 1984. November 8. The Bayh-Dole statute was… Continue Reading →
KEI has received Pfizer and USTR emails and a Pfizer briefing memo to USTR from September 2017, asking the USTR to block a Malaysia Requirement to disclose drug prices. The documents were obtained under a Freedom of Information request to… Continue Reading →
The United States-Mexico-Canada Agreement (USMCA) provisions on the term of protection of test data for new pharmaceutical products has received considerable attention, and in some cases, some inaccurate reports on the agreement have conflated the term for test data protection… Continue Reading →